A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers.

Nicolas AideLaurent PoulainNicolas ElieMélanie BriandFlorence GiffardCécile Blanc-FournierFlorence JolyCharline Lasnon

Published in: EJNMMI research (2021)

The present work demonstrates that PSMA expression is negligible and a fortiori non-sufficient to ensure its usefulness as a prognosticator or a target for a theranostic strategy in ovarian cancers.

Keyphrases

pet ct
pet imaging
photodynamic therapy
fluorescence imaging
poor prognosis
high grade
cancer therapy
positron emission tomography
binding protein
computed tomography
young adults
childhood cancer